Alirocumab Labeling Updated With Dosing for HeFH Patients Undergoing LDL Apheresis
The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH undergoing LDL apheresis.
The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH undergoing LDL apheresis.
Cesium chloride is not approved by the FDA to treat cancer or any other disease.
As valsartan is used to treat various cardiovascular conditions including heart failure and hypertension, patients should continue to take their medications until they have a replacement product,
Symptoms in patients with short latency include fever, rash, and eosinophilia.
For this study, researchers searched several large databases (from 1980 to 2016) for randomized, controlled trials (RCTs) that compared clinical outcomes in patients on DAPT taking PPIs or H2RAs.
Lokelma is a non-absorbed zirconium silicate that preferentially captures potassium in exchange for hydrogen and sodium.
The FDA recommends that healthcare professionals should be cautious when prescribing clarithromycin to patients with heart disease.
The FDA has approved aliskiren oral pellets for hypertension treatment.
FDA releases safety alert that biotin can significantly interfere with certain lab tests and cause incorrect results which may go undetected.
Furosemide-induced acute pancreatitis can occur several hours to up to 7 weeks after starting treatment.